In summary, the dysregulated expression of ACLY, ACSL3, ACSL4, FABP4, FABP5, SCD1, SLC27A5, and SREBP1 in HCC underscores their critical roles in lipid metabolism alterations contributing to tumour development and progression. This evidence concerns the gene ACSL4 and hepatocellular carcinoma.